Point72 Middle East FZE’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,543
| Closed | -$34.2K | – | 1046 |
|
|
2023
Q4 | $34.2K | Buy |
6,543
+1,569
| +32% | +$8.21K | ﹤0.01% | 778 |
|
|
2023
Q3 | $78.4K | Buy |
+4,974
| New | +$78.4K | ﹤0.01% | 684 |
|
|
2023
Q2 | – | Sell |
-863
| Closed | -$24.5K | – | 1611 |
|
|
2023
Q1 | $24.5K | Sell |
863
-946
| -52% | -$26.8K | ﹤0.01% | 847 |
|
|
2022
Q4 | $52.9K | Buy |
+1,809
| New | +$52.9K | ﹤0.01% | 903 |
|